Northwire Canada EditionFriday, October 16, 2026
Northwire
⌕
GOLD 4186.00 +0.4% SILVER 57.26 +0.2% COPPER 6.57 +0.2% OIL 99.00 +1.1% PALLADIUM 1115.75 −1.1% MSV 0.570 +0.0% CCMM 0.520 +7.2% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.640 −1.5% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.780 +2.6% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.347 +2.2% PHNM 0.345 +1.5% SLG 5.60 −1.9% CASA 0.060 +0.0% GOLD 4186.00 +0.4% SILVER 57.26 +0.2% COPPER 6.57 +0.2% OIL 99.00 +1.1% PALLADIUM 1115.75 −1.1% MSV 0.570 +0.0% CCMM 0.520 +7.2% MON 0.385 −6.1% OMI 0.250 +0.0% BUFF 0.800 +2.6% FEO 0.640 −1.5% LIB 0.710 −1.4% NPR 0.620 +0.0% QZM 0.380 +0.0% BVA 0.780 +2.6% ONAU 0.530 +1.9% FMR 0.225 +0.0% GSVR 0.347 +2.2% PHNM 0.345 +1.5% SLG 5.60 −1.9% CASA 0.060 +0.0%
Financings

Comprehensive Healthcare closes $3.5M first tranche

CHS · Price

Executive Summary

  • Comprehensive Healthcare Systems Inc. has closed the first tranche of its non-brokered private placement, raising $3.5 million in gross proceeds.
  • The company issued 7 million units at $0.50 per unit, with each unit consisting of one common share and one-half of a warrant.
  • Insider participation accounted for 13.5% of the tranche, triggering specific regulatory exemptions under MI 61-101 regarding related party transactions.

Key Details

  • Transaction Structure: Non-brokered private placement, first tranche closed.
  • Units Issued: 7,000,000 units.
  • Price Per Unit: $0.50 CAD.
  • Gross Proceeds: $3,500,000 CAD.
  • Warrant Terms (Investors): Each unit includes one-half of a warrant. A whole warrant is exercisable to purchase one common share at an exercise price of $1.00. The warrants are exercisable for a period of three years after closing.
  • Finder Fees: PowerOne Capital Markets Ltd. acted as finder. The company paid $214,200 in cash finder fees.
  • Finder Warrants: The company issued 428,400 finder warrants, exercisable to purchase one common share at an exercise price of $0.50 for a period of three years after closing.
  • Hold Period: All securities issued are subject to a hold period until June 11, 2026.
  • Insider Participation: An insider purchased 945,000 units, representing 13.5% of the units issued in the first tranche.
  • Insider Ownership Impact: The associated common shares represent approximately 3.8% of the issued and outstanding shares upon closing. Assuming the deemed exercise of the associated warrants, this would represent approximately 5.6% of the then issued and outstanding shares.
  • Regulatory Exemptions: The transaction is classified as a related party transaction under TSX-V and Multilateral Instrument 61-101. The company relied on exemptions from formal valuation and minority shareholder approval requirements (sections 5.5(a) and (b), and 5.7(1)(a) of MI 61-101) because the fair market value of the consideration involving related parties did not exceed 25% of the issuer's market capitalization.
Read the original news release →

More from Comprehensive Healthcare Systems Inc